These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9389070)

  • 41. Alternative antibody for the detection of CA125 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access OV Monitor assay on the UniCel Dxl 800 Immunoassay System.
    Holdenrieder S; Molina R; Gion M; Gressner A; Troalen F; Auge JM; Zancan M; Wycislo M; Stieber P
    Clin Chem Lab Med; 2008; 46(5):588-99. PubMed ID: 18598201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The preparation and clinical use of a radioimmunoassay CA125 kit for the diagnosis of epithelial ovarian cancer].
    Liu W
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Dec; 14(6):469-72. PubMed ID: 1303823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Statistical interpretation of CA125 and Bcl-2 in serum of patients with late stage ovarian cancer.
    Camlica H; Duranyildiz D; Tas F; Yasasever V
    Am J Clin Oncol; 2008 Dec; 31(6):585-8. PubMed ID: 19060592
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Total serum sialic acid concentration as a supporting marker of malignancy in ovarian neoplasia.
    Berbeć H; Paszkowska A; Siwek B; Gradziel K; Cybulski M
    Eur J Gynaecol Oncol; 1999; 20(5-6):389-92. PubMed ID: 10609502
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Total lactate dehydrogenase and its isozymes in serum from patients with primary carcinoma of the ovary.
    Kikuchi Y; Hisano A; Kuki E; Hirata J; Nagata I
    Gynecol Obstet Invest; 1991; 31(3):161-5. PubMed ID: 2071055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison between soluble tumor necrosis factor receptors and CA125 in peritoneal fluids as a marker for epithelial ovarian cancer.
    Onsrud M; Shabana A; Austgulen R; Nustad K
    Gynecol Oncol; 1995 May; 57(2):183-7. PubMed ID: 7729731
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Use of Platelet/Lymphocyte Ratio and Cancer Antigen 125 Combined with Magnetic Resonance Diffusion-Weighted Imaging in Diagnosis of Recurrent Ovarian Cancer and Neuropathic Pain.
    Wang N; Li C; Yang Y; Guan Y; Wang F; Wang Y; Zhao W
    World Neurosurg; 2021 May; 149():502-510. PubMed ID: 33326856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Analysis of CA 125 assay system and its diagnostic significance in gynecologic tumors].
    Shimizu Y; Akagaki E; Hirota K; Kono M; Miura S; Okudaira Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2813-20. PubMed ID: 3866801
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors influencing serum CA125II levels in healthy postmenopausal women.
    Pauler DK; Menon U; McIntosh M; Symecko HL; Skates SJ; Jacobs IJ
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):489-93. PubMed ID: 11352859
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiplexed bead-based immunoassay of four serum biomarkers for diagnosis of ovarian cancer.
    Kim YW; Bae SM; Kim IW; Liu HB; Bang HJ; Chaturvedi PK; Battogtokh G; Lim H; Ahn WS
    Oncol Rep; 2012 Aug; 28(2):585-91. PubMed ID: 22641176
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Level of CA125 and hemoglobin as prognostic factors ovarian cancer].
    Chovanec J; Bienertová-Vasků J; Dostálová Z; Minár L
    Ceska Gynekol; 2009 Aug; 74(4):269-73. PubMed ID: 20564980
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative analysis of CA 125, ferritin, beta-2 microglobulin, lactic dehydrogenase levels in serum and peritoneal fluid in patients with ovarian neoplasia.
    Kucukgoz Gulec U; Paydas S; Guzel AB; Buyukkurt S; Seydaoglu G; Vardar MA
    Med Oncol; 2012 Dec; 29(4):2937-43. PubMed ID: 22274916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of serum lactic dehydrogenase levels and its isoenzymes in ovarian dysgerminoma.
    Fujii S; Konishi I; Suzuki A; Okamura H; Okazaki T; Mori T
    Gynecol Oncol; 1985 Sep; 22(1):65-72. PubMed ID: 4018662
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantum Dot-labeled Tags Improve Minimal Detection Limit of CA125 in Ovarian Cancer Cells and Tissues.
    Shojaeian S; Allameh A; Jeddi-Tehrani M; Ghods R; Shojaeian J; Tabatabaei-Panah AS; Zarnani AH
    Iran J Allergy Asthma Immunol; 2018 Aug; 17(4):326-335. PubMed ID: 30537796
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biochemical and morphological differences between CA125 isolated from healthy women and patients with epithelial ovarian cancer from Tunisian population.
    Bouanène H; Saibi W; Mokni M; Sriha B; Ben Fatma L; Ben Limem H; Ben Ahmed S; Gargouri A; Miled A
    Pathol Oncol Res; 2012 Apr; 18(2):325-30. PubMed ID: 21901274
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spectrally separated dual-label upconversion luminescence lateral flow assay for cancer-specific STn-glycosylation in CA125 and CA15-3.
    Ekman M; Salminen T; Raiko K; Soukka T; Gidwani K; Martiskainen I
    Anal Bioanal Chem; 2024 May; 416(13):3251-3260. PubMed ID: 38584178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [CA125 and radioimmunoimaging in monitoring of epithelial ovarian carcinoma].
    Yu Q; Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 1991 Jul; 26(4):235-8, 252. PubMed ID: 1914661
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer.
    Zhang M; Cheng S; Jin Y; Zhao Y; Wang Y
    Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188503. PubMed ID: 33421585
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Markers supplementing CA 125 in ovarian cancer.
    Stenman UH; Alfthan H; Vartiainen J; Lehtovirta P
    Ann Med; 1995 Feb; 27(1):115-20. PubMed ID: 7741989
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elevated serum alpha-hydroxybutyrate dehydrogenase in patients with ovarian carcinoma.
    Kikuchi Y; Momose E; Kizawa I; Kuki E; Kato K
    Acta Obstet Gynecol Scand; 1985; 64(7):553-6. PubMed ID: 4082930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.